Plus   Neg

Build-A-Bear Workshop Sees Lower Revenue, EBIT In Q4 - Quick Facts

Build-A-Bear Workshop, Inc. (BBW), a specialty retailer of plush animals and related products, on Monday provided its financial outlook for the fourth quarter and fiscal year 2020, ahead of its planned presentation at the 23rd Annual ICR Conference.

For the fourth quarter, Build-A-Bear Workshop forecast total revenues in the range of $88.0 million to $92.0 million, down from $104.6 million in the year-ago quarter.

The company noted it had a significant reduction in store traffic during the nine-week holiday period ending January 2, 2021 driven by local COVID-19 restrictions which led to an 18 percent reduction in store operating days. This includes a decline of 10 percent in North America and 66 percent in the United Kingdom.

The company projects earnings before interest and taxes or EBIT for the fourth quarter in a range of $4.0 million to $6.0 million, compared to $7.6 million in the prior-year quarter.

However, Build-A-Bear Workshop forecast cash and cash equivalents at quarter end to be between $32 and $37 million, an increase of approximately $5 to $10 million from the prior year's quarter end, and it expects to have no borrowings under its revolving credit facility at the end of the period.

The company expects to report full results for the fourth quarter and fiscal 2020 year in March, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney World, the Orlando, Florida-based entertainment complex, is easing the health safety guidelines that were rolled out to prevent the spread of the ongoing COVID-19 pandemic. The complex is ending temperature checks in a phased manner following the advice of the Centers for Disease Control and Prevention (CDC) and local health officials. Frito-Lay North America, the convenient foods division of food and beverages giant PepsiCo, Inc., is recalling select Ruffles All Dressed Potato Chips citing the possible presence of undeclared milk ingredients, a known allergen, the U.S. Food and Drug Administration said. According to the agency, the recalled products may have distributed regionally to Walmart's Sam's Club Warehouses. Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have initiated the Biologics License Application (BLA) process with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The companies initiated...
Follow RTT